CanSino Biologics, Inc. Class H(HK:6185)
HK$26.70-0.46 (-1.69%)
HK:6185
CanSino Biologics, Inc. Class H financials statements
HK$26.70
At close:-0.46 (-1.69%)
Want to see HK:6185 full AI Analyst Report?
CanSino Biologics, Inc. Class H (6185) Financial Statements
7 Followers
CanSino Biologics, Inc. Class H Financial Overview
CanSino Biologics, Inc. Class H's market cap is currently ¥13.79B. The company's EPS TTM is ¥0.12; its P/E ratio is 660.78; and it has a dividend yield of 1.31%. CanSino Biologics, Inc. Class H is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is ¥0.38. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.03B | ¥ 846.34M | ¥ 345.18M | ¥ 1.03B | ¥ 4.30B |
| Gross Profit | ¥ 681.82M | ¥ 601.91M | ¥ -876.02M | ¥ -186.61M | ¥ 3.00B |
| Operating Income | ¥ -113.12M | ¥ -375.22M | ¥ -2.04B | ¥ -1.37B | ¥ 1.94B |
| EBITDA | ¥ 60.98M | ¥ -163.84M | ¥ -1.65B | ¥ -1.30B | ¥ 1.87B |
| Net Income | ¥ 27.15M | ¥ -378.88M | ¥ -1.48B | ¥ -909.43M | ¥ 1.91B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.65B | ¥ 3.20B | ¥ 4.12B | ¥ 5.95B | ¥ 7.78B |
| Total Assets | ¥ 7.18B | ¥ 7.96B | ¥ 9.32B | ¥ 11.47B | ¥ 11.87B |
| Total Debt | ¥ 1.29B | ¥ 2.01B | ¥ 2.70B | ¥ 2.70B | ¥ 1.37B |
| Net Debt | ¥ 52.78M | ¥ 456.91M | ¥ 653.34M | ¥ -694.19M | ¥ -4.08B |
| Total Liabilities | ¥ 2.05B | ¥ 3.05B | ¥ 4.03B | ¥ 4.22B | ¥ 3.33B |
| Stockholders' Equity | ¥ 4.96B | ¥ 4.91B | ¥ 5.27B | ¥ 6.75B | ¥ 8.00B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -152.83M | ¥ -626.42M | ¥ -1.53B | ¥ -2.96B | ¥ 811.42M |
| Operating Cash Flow | ¥ 32.49M | ¥ -168.79M | ¥ -908.23M | ¥ -1.89B | ¥ 2.01B |
| Investing Cash Flow | ¥ 355.36M | ¥ 3.96M | ¥ -449.65M | ¥ -1.19B | ¥ -2.53B |
| Financing Cash Flow | ¥ -703.03M | ¥ -334.18M | ¥ -7.58M | ¥ 854.60M | ¥ 1.56B |
Currency in CNY
